Literature DB >> 8206500

Carcinoma of buccal mucosa: incidence of regional lymph node involvement.

I K Dhawan1, K Verma, R K Khazanchi, N C Madan, N K Shukla, R Saxena.   

Abstract

Histopathological findings in 57 surgical specimens of T3 and T4 buccal mucosa cancers are reviewed. The incidence of the well-differentiated tumours (including verrucous carcinoma) was 61%. A moderate degree of lymphocytic infiltration of the tumour was present in 37% of patients. Histologically proven cervical lymph node deposits were present in only 16% of the patients. Amongst the group of patients with clinically enlarged lymph nodes, metastatic disease was histologically demonstrated in 17.5% at level I and 14% at level II of neck nodes. Amongst group of patients with no palpable nodes in the neck, metastatic disease was histologically demonstrated in 11.7% at level I and 9% at level II of neck nodes. These findings contra-indicate an elective neck dissection and indicate the need to confirm histologically the presence of lymph node deposits doing a radical neck dissection in patients with buccal mucosa cancer. This well-differentiated tumour has a much lower tendency to metastasize than cancers in other sites of the oral cavity.

Entities:  

Mesh:

Year:  1993        PMID: 8206500

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  3 in total

Review 1.  Management of gingivobuccal complex cancer.

Authors:  Sanjeev Misra; Arun Chaturvedi; N C Misra
Journal:  Ann R Coll Surg Engl       Date:  2008-08-12       Impact factor: 1.891

2.  Metastatic involvement of level IIb nodal station in oral squamous cell carcinoma: A clinicopathological study.

Authors:  Partha S Chakraborty; Ashok Kumar Das; Ashutosh Vatsyayan; Tashnin Rahman; Rajjyoti Das; Seemanta Kumar Medhi; Kishore Das; Jagganath Dev Sharma
Journal:  Natl J Maxillofac Surg       Date:  2019 Jan-Jun

3.  Elective neck dissection versus wait-and-see policy in cT1N0 buccal squamous cell carcinoma.

Authors:  Qigen Fang; Hua Gao; Qing Gao; Jinlan Sun; Peng Li; Meng Cui; Enxi Zhang; Wenlong Yin; Yuanyuan Dong
Journal:  BMC Cancer       Date:  2020-06-09       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.